ESG at Rigel

At Rigel, our approach to environmental, social and governance (“ESG”) factors is consistent with our mission and corporate values. We are committed to conducting business in a safe and environmentally sustainable manner that promotes the health of our employees, patients, our community and the environment.

View 2023 ESG Report


Rigel is a commercial pharmaceutical company that operates without physical manufacturing facilities. We focus on innovative therapeutic advancements with a lean and agile infrastructure. We leverage external expertise and partnerships to bring new therapies to patients while maintaining a commitment to regulatory compliance and patient welfare.

While we do not engage in any on-site manufacturing, we are committed to minimizing our environmental impact and promoting sustainable practices. Our environmental efforts are directed towards making a positive difference in the communities in which we operate and contributing to a healthier planet.


At Rigel, we believe that our diverse workforce brings a wide variety of experiences and perspectives, which sparks creativity and innovation. We are committed to attracting, retaining, and developing a diverse workforce where differences are valued and integrated into our work environment. We value having a workforce that is talented, diverse, and committed to achieving our corporate goals to create better outcomes for patients.

Rigel is committed to giving back to the communities where we live and do business. We believe that the dedication and generosity of our employees can positively impact our communities. Our employees are encouraged to volunteer or donate to charities or causes. In keeping with our beliefs, we participate annually in the South San Francisco Pump It Up for Platelets Walk in support of the immune thrombocytopenia (ITP) community. We also support the ITP community and our Rigel values (including Commitment to Patients) by participating in ITP Awareness Month every year.


At Rigel, our commitment to ESG is integral to our corporate governance. Oversight of our ESG strategy and policies occurs at multiple levels within our organization. The Board of Directors actively exercises ESG oversight, supported by our executive leadership. Specifically, the Corporate Governance, Health Care Compliance Oversight, and Nominating Committee of our Board holds key responsibilities in monitoring Rigel’s ESG initiatives. This committee receives regular briefings from our executive leadership on ESG related matters. Additionally, we have instituted a cross-functional ESG committee dedicated to ensuring Rigel’s sustainability commitment. This ESG committee is comprised of various functions including clinical development, commercial operations, legal, compliance, supply chain management, human resources, and other pertinent areas.